Maxygen Announces MAXY-G34 Licensing Arrangement with Cangene for Acute Radiation Syndrome

News   May 08, 2009

 
Maxygen Announces MAXY-G34 Licensing Arrangement with Cangene for Acute Radiation Syndrome
 
 
 

RELATED ARTICLES

Genetics of Mitochondrial Mutation Exposed

News

A study has revealed how fatal mitochondrial disease can appear unexpectedly in families without history of such diseases.

READ MORE

Ancient Fish Genes May Hold Key to Spinal Cord Repair

News

A study has found that genes controlling spinal cord repair in the lamprey fish are also active in mammals, which could provide a blueprint for treatment.

READ MORE

Synaptic Proteins May Be Starting Point for Dementia Treatment

News

A new study has identified key proteins, located at the brain's synaptic connections, which may be viable targets for dementia treatment.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE